Charles Schwab’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.4M Buy
1,316,496
+53,559
+4% +$1.93M 0.01% 1142
2025
Q1
$49.8M Sell
1,262,937
-6,576
-0.5% -$259K 0.01% 1074
2024
Q4
$38.2M Buy
1,269,513
+84,904
+7% +$2.56M 0.01% 1320
2024
Q3
$27.7M Buy
1,184,609
+7,939
+0.7% +$186K 0.01% 1515
2024
Q2
$20.9M Buy
1,176,670
+31,101
+3% +$553K ﹤0.01% 1655
2024
Q1
$17.4M Buy
1,145,569
+13,673
+1% +$208K ﹤0.01% 1696
2023
Q4
$19.3M Buy
1,131,896
+19,214
+2% +$328K ﹤0.01% 1616
2023
Q3
$9.3M Buy
1,112,682
+31,872
+3% +$266K ﹤0.01% 1946
2023
Q2
$26.8M Buy
1,080,810
+35,058
+3% +$871K 0.01% 1281
2023
Q1
$15.7M Buy
1,045,752
+27,445
+3% +$413K ﹤0.01% 1635
2022
Q4
$12M Buy
1,018,307
+27,449
+3% +$325K ﹤0.01% 1755
2022
Q3
$5.87M Buy
990,858
+49,186
+5% +$291K ﹤0.01% 2128
2022
Q2
$4M Sell
941,672
-13,751
-1% -$58.5K ﹤0.01% 2286
2022
Q1
$9.09M Buy
955,423
+17,029
+2% +$162K ﹤0.01% 2008
2021
Q4
$17.8M Buy
938,394
+23,927
+3% +$455K 0.01% 1670
2021
Q3
$30.4M Buy
914,467
+45,885
+5% +$1.53M 0.01% 1215
2021
Q2
$33.7M Buy
868,582
+27,619
+3% +$1.07M 0.01% 1160
2021
Q1
$40.5M Buy
840,963
+113,794
+16% +$5.48M 0.01% 973
2020
Q4
$37.8M Buy
727,169
+34,116
+5% +$1.77M 0.02% 961
2020
Q3
$18.5M Buy
693,053
+44,395
+7% +$1.19M 0.01% 1251
2020
Q2
$12.6M Buy
648,658
+96,722
+18% +$1.88M 0.01% 1491
2020
Q1
$5.43M Buy
551,936
+38,888
+8% +$383K ﹤0.01% 1794
2019
Q4
$5.7M Buy
513,048
+45,399
+10% +$504K ﹤0.01% 1955
2019
Q3
$2.63M Buy
467,649
+31,216
+7% +$175K ﹤0.01% 2291
2019
Q2
$3.78M Buy
436,433
+47,585
+12% +$412K ﹤0.01% 2109
2019
Q1
$3.13M Buy
388,848
+40,634
+12% +$327K ﹤0.01% 2200
2018
Q4
$1.43M Buy
348,214
+18,567
+6% +$76.1K ﹤0.01% 2429
2018
Q3
$1.85M Buy
329,647
+15,895
+5% +$89.1K ﹤0.01% 2448
2018
Q2
$4.13M Buy
313,752
+45,578
+17% +$599K ﹤0.01% 2100
2018
Q1
$3.81M Buy
268,174
+1,204
+0.5% +$17.1K ﹤0.01% 2076
2017
Q4
$2.19M Buy
266,970
+23,485
+10% +$193K ﹤0.01% 2273
2017
Q3
$2.89M Buy
243,485
+155,535
+177% +$1.84M ﹤0.01% 2138
2017
Q2
$884K Buy
87,950
+15,900
+22% +$160K ﹤0.01% 2497
2017
Q1
$840K Sell
72,050
-26,200
-27% -$305K ﹤0.01% 2477
2016
Q4
$457K Buy
98,250
+39,200
+66% +$182K ﹤0.01% 2688
2016
Q3
$458K Hold
59,050
﹤0.01% 2635
2016
Q2
$358K Hold
59,050
﹤0.01% 2714
2016
Q1
$504K Hold
59,050
﹤0.01% 2576
2015
Q4
$705K Hold
59,050
﹤0.01% 2501
2015
Q3
$596K Buy
59,050
+9,300
+19% +$93.9K ﹤0.01% 2555
2015
Q2
$826K Buy
49,750
+8,650
+21% +$144K ﹤0.01% 2503
2015
Q1
$637K Buy
41,100
+6,700
+19% +$104K ﹤0.01% 2546
2014
Q4
$545K Hold
34,400
﹤0.01% 2589
2014
Q3
$368K Hold
34,400
﹤0.01% 2704
2014
Q2
$324K Sell
34,400
-15,400
-31% -$145K ﹤0.01% 2823
2014
Q1
$344K Hold
49,800
﹤0.01% 2743
2013
Q4
$195K Buy
49,800
+31,600
+174% +$124K ﹤0.01% 2958
2013
Q3
$94K Hold
18,200
﹤0.01% 3038
2013
Q2
$121K Buy
+18,200
New +$121K ﹤0.01% 3008